ABTCL.SN
Abbott Laboratories News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 3,
"returned": 3,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "b239b078-fae2-4a91-a5cd-02d517a3d7ff",
"title": "What the Options Market Tells Us About Abbott Laboratories - Abbott Laboratories (NYSE:ABT)",
"description": "",
"keywords": "",
"snippet": "Loading... Loading...\n\nDeep-pocketed investors have adopted a bullish approach towards Abbott Laboratories ABT, and it's something market players shouldn't igno...",
"url": "https://www.benzinga.com/insights/options/24/05/38566419/what-the-options-market-tells-us-about-abbott-laboratories",
"image_url": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
"language": "en",
"published_at": "2024-05-01T20:46:05.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "ABTCL.SN",
"name": "Abbott Laboratories",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 157.24069,
"sentiment_score": 0.099027,
"highlights": [
{
"highlight": "Deep-pocketed investors have adopted a bullish approach towards <em>Abbott</em> <em>Laboratories</em> ABT, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",
"sentiment": 0.1128,
"highlighted_in": "main_text"
},
{
"highlight": "We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for <em>Abbott</em> <em>Laboratories</em>. This level of activity is out of the ordinary.\n\nThe general mood among these heavyweight investors is divided, with 50% leaning bullish and 25% bearish.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Expected Price Movements\n\nBased on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $105.0 to $130.0 for <em>Abbott</em> <em>Laboratories</em> over the recent three months.",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Abbott</em> <em>Laboratories</em> 30-Day Option Volume & Interest Snapshot\n\nBiggest Options Spotted:\n\nSymbol PUT/CALL Trade Type Sentiment Exp.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Laboratories</em>\n\nAbbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Where Is <em>Abbott</em> <em>Laboratories</em> Standing Right Now?\n\nCurrently trading with a volume of 4,096,535, the ABT's price is up by 0.3%, now at $106.29.\n\nRSI readings suggest the stock is currently may be approaching oversold.\n\nAnticipated earnings release is in 78 days.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "What The Experts Say On <em>Abbott</em> <em>Laboratories</em>\n\nA total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $129.5.\n\nAn analyst from RBC Capital persists with their Outperform rating on <em>Abbott</em> <em>Laboratories</em>, maintaining a target price of $125.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for <em>Abbott</em> <em>Laboratories</em>, targeting a price of $140.\n\nAn analyst from Citigroup persists with their Buy rating on <em>Abbott</em> <em>Laboratories</em>, maintaining a target price of $128.",
"sentiment": -0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "An analyst from Evercore ISI Group has decided to maintain their Outperform rating on <em>Abbott</em> <em>Laboratories</em>, which currently sits at a price target of $125.\n\nOptions are a riskier asset compared to just trading the stock, but they have higher profit potential.",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "If you want to stay updated on the latest options trades for <em>Abbott</em> <em>Laboratories</em>, Benzinga Pro gives you real-time options trades alerts.",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "What the Options Market Tells Us About <em>Abbott</em> <em>Laboratories</em> - <em>Abbott</em> <em>Laboratories</em> (NYSE:ABT)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "24cb1b3b-a982-4984-a2f0-17787ed6d318",
"title": "Is Trending Stock Abbott Laboratories (ABT) a Buy Now?",
"description": "Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.",
"keywords": "stock, stocks, investment, investment advice, investing, online trading, online investment, online stock trading, stock market, financial, financial planning, quote, quotes, stock quotes",
"snippet": "This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herei...",
"url": "https://www.zacks.com/stock/news/2265759/is-trending-stock-abbott-laboratories-abt-a-buy-now?cid=CS-ZC-FT-tale_of_the_tape|most_searched_stocks-2265759",
"image_url": "https://staticx-tuner.zacks.com/images/default_article_images/default222.jpg",
"language": "en",
"published_at": "2024-05-01T13:00:18.000000Z",
"source": "zacks.com",
"relevance_score": null,
"entities": [
{
"symbol": "ABTCL.SN",
"name": "Abbott Laboratories",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 127.77199,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Is Trending Stock <em>Abbott</em> <em>Laboratories</em> (ABT) a Buy Now?",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "05ae6b37-b6a9-461c-ba95-253337ff2eb1",
"title": "Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories",
"description": "In this article, we will take a look into Abbott Laboratories's (ABT) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Inste",
"keywords": "GuruFocus, Article, News, GuruFocus Research, ABT",
"snippet": "In this article, we will take a look into Abbott Laboratories's (ABT, Financial) DCF analysis, a reliable and data-driven approach to estimating its intrinsic v...",
"url": "https://www.gurufocus.com/news/2423289/invest-with-confidence-intrinsic-value-unveiled-of-abbott-laboratories",
"image_url": "https://static.gurufocus.com/logos/0C0000096K.png?12",
"language": "en",
"published_at": "2024-05-01T12:00:11.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ABTCL.SN",
"name": "Abbott Laboratories",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 127.765274,
"sentiment_score": 0.7491,
"highlights": [
{
"highlight": "This valuation indicates that the <em>Abbott</em> <em>Laboratories</em> is modestly overvalued, accompanied by a margin of safety of -89.77%. You can always switch to using Free Cash Flow per Share to calculate the real DCF model on our DCF calculator page.",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "Invest with Confidence: Intrinsic Value Unveiled of <em>Abbott</em> <em>Laboratories</em>",
"sentiment": 0.6908,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "ABTCL.SN",
"total_documents": 3,
"sentiment_avg": 0.2827090099453926
}
]
}
Other details
Exchange
- Santiago Stock Exchange
- equity
- N/A
- cl